Gregory Mertz is an Infectious Disease physician affiliated with University of New Mexico. OpenAlex indexes 193 publications with 7,406 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Walter St NE
Suite 104
Albuquerque, NM 871022534
Telephone
505-848-3730Provider last certified this registry record 25 Sept 2024.
Clinical trials
- Hantavirus Transmission in Households in Chile
Sponsor: University of New Mexico
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
5 NIH research awards on record, funded 1985–2014 per NIH RePORTER. The latest:
- Andes virus transmission and pathogenesis in Chile
University of New Mexico Health Scis Ctr
FY2014$549,349U01AI045452 - Andes virus transmission and pathogenesis in Chile
University of New Mexico Health Scis Ctr
FY2013$516,389U01AI045452 - Andes virus transmission and pathogenesis in Chile
University of New Mexico Health Scis Ctr
FY2012$549,350U01AI045452
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study
The Lancet Infectious Diseases
2024 - Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
The Lancet Respiratory Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mauricio Tohen, MD, DRPH, MBA
University of New Mexico
Howard Yonas, MD
University of New Mexico
Rhoshel Lenroot, MD
University of New Mexico
Mark Unruh, MD
University of New Mexico
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”